-+ 0.00%
-+ 0.00%
-+ 0.00%
Nanoform Finland Partners With CDMO for Biologics Manufacturing
Share
Listen to the news
01:37 AM EST, 11/17/2026 (MT Newswires) -- Nanoform Finland (NANOFH.HE) partnered with a contract development and manufacturing organization, or CDMO, for the aseptic manufacturing of ultra-high concentration biologics. Under the deal, the partner will implement the medicine performance-enhancing company's biologics technology at its existing aseptic manufacturing facility in Germany, according to a Tuesday release. The partners are targeting good manufacturing practice readiness in the second half of 2027, which will be followed by a planned first customer clinical trial of a subcutaneous ultra-high-concentration suspension biologic product.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending